Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maulasri Bhatta"'
Autor:
Hans Minderman, Maulasri Bhatta, Gautam N Shenoy, Jenni L Loyall, Brian D Gray, Meghana Bapardekar, Alexis Conway, Raymond J Kelleher Jr, Beatriz M Carreno, Gerald Linette, Leonard D Shultz, Sathy V Balu-Iyer, Koon Yan Pak, Richard B Bankert
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/459c116054b34eebac5200ea18da9508
Autor:
Gautam N Shenoy, Christopher J Greene, Maulasri Bhatta, Miren L Baroja, Jenni L Loyall, Sathy V Balu‐Iyer, Raymond J Kelleher Jr, Beatriz M Carreno, Gerald P Linette, Leonard D Shultz, Richard B Bankert
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 2, Pp n/a-n/a (2021)
Abstract Objectives With a rapidly growing list of candidate immune‐based cancer therapeutics, there is a critical need to generate highly reliable animal models to preclinically evaluate the efficacy of emerging immune‐based therapies, facilitat
Externí odkaz:
https://doaj.org/article/882f932df6194fc1b199c27017cea9e8
Publikováno v:
Cells, Vol 10, Iss 11, p 3155 (2021)
Exosomes are a subset of extracellular vesicles (EVs) that are released by cells and play a variety of physiological roles including regulation of the immune system. Exosomes are heterogeneous and present in vast numbers in tumor microenvironments. A
Externí odkaz:
https://doaj.org/article/cedcc5d4d6e04b1396b7cce86f5b50d9
Autor:
Meghana V. Bapardekar, Gautam N Shenoy, Leonard D. Shultz, Gerald P. Linette, Koon Y. Pak, Sathy V. Balu-Iyer, Richard B. Bankert, Maulasri Bhatta, Hans Minderman, Jenni L Loyall, Brian D. Gray, Alexis Conway, Beatriz M. Carreno, Kunle Odunsi, Raymond J. Kelleher
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
BackgroundThe human tumor microenvironment (TME) is a complex and dynamic milieu of diverse acellular and cellular components, creating an immunosuppressive environment, which contributes to tumor progression. We have previously shown that phosphatid
Autor:
Aftab Alam, Eric Levanduski, Maulasri Bhatta, Sharon Senchanthisai, Sheila Jani Sait, Jianmin Wang, Scott I. Abrams I. Abrams, Prasenjit Dey
Publikováno v:
Cancer Research. 82:2119-2119
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, the five-year survival rate of PDAC patient is around ten percent. It is fourth largest cause of cancer related death and is projected to become the second deadliest cancer by 2
Autor:
Leonard D. Shultz, Maulasri Bhatta, Gerald P. Linette, Sathy V. Balu-Iyer, Christopher J. Greene, Raymond J. Kelleher, Jenni L Loyall, Gautam N Shenoy, Richard B. Bankert, Miren L. Baroja, Beatriz M. Carreno
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 2, Pp n/a-n/a (2021)
Clinical & Translational Immunology
Clinical & Translational Immunology
Objectives With a rapidly growing list of candidate immune‐based cancer therapeutics, there is a critical need to generate highly reliable animal models to preclinically evaluate the efficacy of emerging immune‐based therapies, facilitating succe
Autor:
Gautam N Shenoy, Maulasri Bhatta, Raymond J. Kelleher, Joel M. Bernstein, Richard B. Bankert, Jenni L Loyall
Publikováno v:
Immunol Invest
BACKGROUND: T cells present in chronic inflammatory tissues such as nasal polyps (from chronic rhinosinusitis patients) have been demonstrated to be hypo-responsive to activation via the TCR, similar to tumor-specific T cells in multiple different hu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20820c79ea63dd4d6aa54afbcbc63ea
https://europepmc.org/articles/PMC7554261/
https://europepmc.org/articles/PMC7554261/
Autor:
Aftab Alam, Eric Levanduski, Parker Denz, Helena Solleiro Villavicencio, Maulasri Bhatta, Lamees Alhorebi, Yali Zhang, Eduardo Cortes Gomez, Brian Morreale, Sharon Senchanthisai, Jun Li, Steven G. Turowski, Sandra Sexton, Sheila Jani Sait, Prashant K. Singh, Jianmin Wang, Anirban Maitra, Pawel Kalinski, Ronald A. DePinho, Huamin Wang, Wenting Liao, Scott I. Abrams, Brahm H. Segal, Prasenjit Dey
Publikováno v:
Cancer Cell
In this issue of Cancer Cell, Aftab et al. identify a pro-inflammatory cytokine, IL-33, that is released as a chemoattractant for type 2 immune cells in response to the intratumoral mycobiome. Depletion of fungi or deletion of IL-33 in cancer cells s
Publikováno v:
Cancer Research. 81:2679-2679
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that remains largely incurable. Although the cause for this profound therapeutic resistance is poorly understood, it is however partly blamed on signaling factors present in the tumor m
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 5, Pp 1-14 (2018)
Cell Death and Disease, Vol 9, Iss 5, Pp 1-14 (2018)
Persistent vascular injury and degeneration in diabetes are attributed in part to defective reparatory function of angiogenic cells. Our recent work implicates endoplasmic reticulum (ER) stress in high-glucose-induced bone marrow (BM) progenitor dysf